Literature DB >> 27326049

Towards a reappraisal of the TACTICS TIMI 18 trial in the era of modern pharmacological and interventional therapies.

Wail Nammas1.   

Abstract

Keywords:  Coronary Artery Disease

Year:  2012        PMID： 27326049      PMCID： PMC4832619          DOI： 10.1136/heartasia-2012-010154

Source DB:  PubMed          Journal:  Heart Asia        ISSN： 1759-1104


× No keyword cloud information.
  6 in total

1.  Early versus delayed invasive intervention in acute coronary syndromes.

Authors:  Shamir R Mehta; Christopher B Granger; William E Boden; Philippe Gabriel Steg; Jean-Pierre Bassand; David P Faxon; Rizwan Afzal; Susan Chrolavicius; Sanjit S Jolly; Petr Widimsky; Alvaro Avezum; Hans-Jurgen Rupprecht; Jun Zhu; Jacques Col; Madhu K Natarajan; Craig Horsman; Keith A A Fox; Salim Yusuf
Journal:  N Engl J Med       Date:  2009-05-21       Impact factor: 91.245

2.  2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.

Authors:  R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; James Patrick Zidar
Journal:  J Am Coll Cardiol       Date:  2011-05-10       Impact factor: 24.094

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide.

Authors:  Shaun G Goodman; David Fitchett; Paul W Armstrong; Mary Tan; Anatoly Langer
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

5.  5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome.

Authors:  Peter Damman; Alexander Hirsch; Fons Windhausen; Jan G P Tijssen; Robbert J de Winter
Journal:  J Am Coll Cardiol       Date:  2010-01-04       Impact factor: 24.094

6.  Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial.

Authors:  Gilles Montalescot; Guillaume Cayla; Jean-Philippe Collet; Simon Elhadad; Farzin Beygui; Hervé Le Breton; Rémi Choussat; Florence Leclercq; Johanne Silvain; François Duclos; Mounir Aout; Jean-Luc Dubois-Randé; Olivier Barthélémy; Grégory Ducrocq; Anne Bellemain-Appaix; Laurent Payot; Philippe-Gabriel Steg; Patrick Henry; Christian Spaulding; Eric Vicaut
Journal:  JAMA       Date:  2009-09-02       Impact factor: 56.272
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.